Biliary pancreatosis
Conditions
Interventions
propofol group:induction and maitainance by propofol
remimazolam group: induction and maitainance by remimazolam
Sponsors
The Second Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged >=18 years, ASA grade 1-3; 2.Therapeutic ERCP surgery was performed at an elective date, and the operation time was expected to exceed 30 minutes. The therapeutic indications of ERCP included choledocholithiasis, biliary stenosis, gallbladder cancer, pancreatic disease, and post liver transplantation, etc.; 3.Volunteer to participate in clinical study and sign written informed consent.
Exclusion criteria
Exclusion criteria: 1.Emergency ERCP examination or treatment; 2.ERCP examination alone, and the expected operation time is less than 30 minutes; 3.Abnormal head and neck pathology, head and neck surgery or radiotherapy history, suspected difficult airway; 4.Patients with full stomach and high risk of reflux and aspiration; 5.Severe cardiopulmonary insufficiency, such as EF < 40% and FEVC < 50%; Uncontrolled high blood pressure; 6.Allergic to propofol, remazolam, opioids, muscle relaxants or other sedative narcotic drugs or ingredients; 7.Pregnant women or breastfeeding women, or have pregnancy plan within the recent 1 month; 8.History of mental disorder or epilepsy; 9.Other researchers deem it inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemodynamics; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wake up of time;The quality of waking;Satisfaction survey;Adverse events;Basic data analysis; | — |
Countries
China
Contacts
Public ContactDai Ruping
The Second Xiangya Hospital, Central South University
Outcome results
None listed